J&J Shares Slip as Covid-19 Trial Pause Overshadows Outlook

(Bloomberg) -- Johnson & Johnson shares fell after the drugmaker was forced to pause its late-stage study of a coronavirus vaccine, overshadowing an improved financial outlook for the year.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.